Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inwards

Showing results (251-260 of 382) with videos related to

Pageof 39
Sort By:
Cancer|October 20, 2011
Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)Tait D Shanafelt, Neil E Kay, Kari G Rabe, et al.
Scientific Reports|December 1, 2023
COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patientsMary J Kasten, Brian D Lahr, Anusha Parisapogu, et al.
Blood Cancer Journal|September 26, 2021
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E studySanjal H Desai, Betsy LaPlant, William R Macon, et al.
Leukemia & Lymphoma|June 24, 2008
Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment GroupThomas E Witzig, Susan M Geyer, Paul J Kurtin, et al.
Blood|May 22, 2012
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experienceAnita D'Souza, Martha Lacy, Morie Gertz, et al.
Bone Marrow Transplantation|July 15, 2003
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphomaR Howe, I N M Micallef, D J Inwards, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 17, 2020
Xanthogranulomatous epithelial tumor: report of 6 cases of a novel, potentially deceptive lesion with a predilection for young womenKaren J Fritchie, Jorge Torres-Mora, Carrie Inwards, et al.
Bone Marrow Transplantation|October 12, 2010
Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early interventionS Sinha, D Gastineau, I Micallef, et al.
American Journal of Hematology|March 1, 2019
Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication studyYucai Wang, Thomas M Habermann, Sophia S Wang, et al.
British Journal of Haematology|August 8, 2006
Absolute lymphocyte count predicts overall survival in follicular lymphomasMustaqeem Siddiqui, Kay Ristow, Svetomir N Markovic, et al.
Pageof 39

Showing results (251-260 of 382) with videos related to

Sort By:
Pageof 39
Cancer|October 20, 2011
Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)Tait D Shanafelt, Neil E Kay, Kari G Rabe, et al.
Scientific Reports|December 1, 2023
COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patientsMary J Kasten, Brian D Lahr, Anusha Parisapogu, et al.
Blood Cancer Journal|September 26, 2021
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E studySanjal H Desai, Betsy LaPlant, William R Macon, et al.
Leukemia & Lymphoma|June 24, 2008
Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment GroupThomas E Witzig, Susan M Geyer, Paul J Kurtin, et al.
Blood|May 22, 2012
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experienceAnita D'Souza, Martha Lacy, Morie Gertz, et al.
Bone Marrow Transplantation|July 15, 2003
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphomaR Howe, I N M Micallef, D J Inwards, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 17, 2020
Xanthogranulomatous epithelial tumor: report of 6 cases of a novel, potentially deceptive lesion with a predilection for young womenKaren J Fritchie, Jorge Torres-Mora, Carrie Inwards, et al.
Bone Marrow Transplantation|October 12, 2010
Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early interventionS Sinha, D Gastineau, I Micallef, et al.
American Journal of Hematology|March 1, 2019
Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication studyYucai Wang, Thomas M Habermann, Sophia S Wang, et al.
British Journal of Haematology|August 8, 2006
Absolute lymphocyte count predicts overall survival in follicular lymphomasMustaqeem Siddiqui, Kay Ristow, Svetomir N Markovic, et al.
Pageof 39